MBLY Stock Analysis: Mobileye Global Common Stock | NASDAQ
Auto Parts | NASDAQ, USA | Market Cap: 7.698m USD | 12M Return: -42.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 54.7M
EPS Trend: -91.2%
Qual. Beats: 1
Rev. Trend: -9.3%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 3.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Mobileye Global Inc. (NASDAQ: MBLY) is a Jerusalem-based technology company that designs advanced driver assistance systems (ADAS) and autonomous driving solutions, operating through two segments: Mobileye and Moovit. Its product portfolio spans entry-level front-camera safety systems (Base ADAS and Cloud-Enhanced ADAS), higher-end Surround ADAS and SuperVision systems offering hands-off highway and consumer driving capabilities, and the fully autonomous Mobileye Drive platform targeted at robotaxis, public transit, and goods delivery fleets. The company sells its EyeQ system-on-chip (SoC) and supporting software stack to automakers through automotive suppliers, embedding its technology into the vehicles of major OEMs worldwide.
Mobileye was founded in 1999 and remains a subsidiary of Intel Corporation following its 2022 IPO. As a chip-plus-software supplier within the Automotive Parts & Equipment sub-industry (GICS Consumer Discretionary), its business model centers on design wins with OEMs, where adoption of ADAS is increasingly driven by regulatory mandates such as automatic emergency braking requirements in the U.S. and EU, supporting a long-term secular shift toward software-defined and increasingly autonomous vehicles.
- China OEM order weakness pressures quarterly revenue outlook
- SuperVision and Chauffeur design wins expand higher-margin pipeline
- NVIDIA and Qualcomm competition intensifies in autonomous driving SoCs
| Net Income: -4.11b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.06 > 0.02 and ΔFCF/TA 2.35 > 1.0 |
| NWC/Revenue: 78.15% < 20% (prev 103.9%; Δ -25.73% < -1%) |
| CFO/TA 0.07 > 3% & CFO 579.2m > Net Income -4.11b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 4.76 > 1.5 & < 3 |
| Outstanding Shares: last quarter (817.0m) vs 12m ago 0.62% < -2% |
| Gross Margin: 48.26% > 18% (prev 48.25%; Δ 0.02% > 0.5%) |
| Asset Turnover: 18.97% > 50% (prev 14.83%; Δ 4.14% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.18 (Total Current Assets 1.99b - Total Current Liabilities 419.0m) / Total Assets 8.73b |
| B: -0.83 (Retained Earnings -7.27b / Total Assets 8.73b) |
| C: -0.39 (EBIT TTM -4.16b / Avg Total Assets 10.6b) |
| D: 14.30 (Book Value of Equity 8.16b / Total Liabilities 571.0m) |
| Altman-Z'' = 10.85 = AAA |
| DSRI: 0.96 (Receivables 226.0m/217.0m, Revenue 2.01b/1.85b) |
| GMI: 1.00 (GM 48.25% / 48.26%) |
| AQI: 0.91 (AQ_t 0.72 / AQ_t-1 0.79) |
| SGI: 1.09 (Revenue 2.01b / 1.85b) |
| TATA: -0.54 (NI -4.11b - CFO 579.2m) / TA 8.73b) |
| Beneish M = -3.11 (Cap -4..+1) = AA |
As of July 11, 2026, the stock is trading at USD 9.55 with a total of 8,990,450 shares traded. Over the past week, the price has changed by -0.21%, over one month by +4.49%, over three months by +31.91% and over the past year by -42.71%.
Current recommended Stop Loss: 8.80 (which is 7.9% or 1.3 ATR below the current price).
Mobileye Global Common Stock has received a consensus analysts rating of 3.89. Therefore, it is recommended to buy MBLY.
- StrongBuy: 12
- Buy: 2
- Hold: 13
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 13.1 | 36.6% |
P/E Forward = 36.7647
P/S = 3.822
P/B = 0.9872
P/EG = 0.6135
Revenue TTM = 2.01b USD
EBIT TTM = -4.16b USD
EBITDA TTM = -3.64b USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 67.0m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -1.28b USD (calculated: Debt 67.0m - CCE 1.34b)
Enterprise Value = 6.42b USD (7.70b + Debt 67.0m - CCE 1.34b)
Interest Coverage Ratio = unknown (Ebit TTM -4.16b / Interest Expense TTM 0.0)
EV/FCF = 13.32x (Enterprise Value 6.42b / FCF TTM 482.2m)
FCF Yield = 7.51% (FCF TTM 482.2m / Enterprise Value 6.42b)
FCF Margin = 23.94% (FCF TTM 482.2m / Revenue TTM 2.01b)
Net Margin = -204.0% (Net Income TTM -4.11b / Revenue TTM 2.01b)
Gross Margin = 48.26% ((Revenue TTM 2.01b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 49.28% (prev 45.29%)
Tobins Q-Ratio = 0.74 (Enterprise Value 6.42b / Total Assets 8.73b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 67.0m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -3.29b (EBIT -4.16b * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 4.76 (Total Current Assets 1.99b / Total Current Liabilities 419.0m)
Debt / Equity = 0.01 (Debt 67.0m / totalStockholderEquity, last quarter 8.16b)
Debt / EBITDA = 0.35 (negative EBITDA) (Net Debt -1.28b / EBITDA -3.64b)
Debt / FCF = -2.65 (Net Debt -1.28b / FCF TTM 482.2m)
Total Stockholder Equity = 11.0b (last 4 quarters mean from totalStockholderEquity)
RoA = -38.69% (Net Income -4.11b / Total Assets 8.73b)
RoE = -37.31% (Net Income TTM -4.11b / Total Stockholder Equity 11.0b)
RoCE = -50.02% (EBIT -4.16b / Capital Employed (Total Assets 8.73b - Current Liab 419.0m))
RoIC = -40.00% (negative operating profit) (NOPAT -3.29b / Invested Capital 8.22b)
WACC = 13.82% (E(7.70b)/V(7.76b) * Re(13.94%) + D(67.0m)/V(7.76b) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 13.94% (= CAPM, Blume Beta Adj.) -> capped to 13.17%
Shares (quarterly) Correlation: 52.29 | Cagr: 0.60%
[DCF] Terminal Value 62.35% ; FCFF base≈447.7m ; Y1≈513.2m ; Y5≈755.3m
[DCF] Fair Price = 28.72 (EV 5.74b - Net Debt -1.28b = Equity 7.02b / Shares 244.4m; r=13.82% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -91.15 | EPS CAGR: -44.27% | SUE: 2.81 | # QB: 1
Revenue Correlation: -9.31 | Revenue CAGR: -0.61% | SUE: 4.0 | # QB: 1
EPS current Quarter (2026-06-30): EPS=0.06 | Chg30d=-0.35% | Revisions=+0% | Analysts=22
EPS next Quarter (2026-09-30): EPS=0.05 | Chg30d=+0.20% | Revisions=-82% | Analysts=22
EPS current Year (2026-12-31): EPS=0.28 | Chg30d=-0.04% | Revisions=+80% | GrowthEPS=-21.0% | GrowthRev=+4.5%
EPS next Year (2027-12-31): EPS=0.36 | Chg30d=-1.11% | Revisions=-17% | GrowthEPS=+28.0% | GrowthRev=+12.6%
[Analyst] Revisions Ratio: +10% (up=27, down=22)